# Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

> **NCT00982904** · PHASE1 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 108 (actual)

## Conditions studied

- Human African Trypanosomiasis

## Interventions

- **DRUG:** Fexinidazole/Placebo

## Key facts

- **NCT ID:** NCT00982904
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2017-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982904, "Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00982904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*